Lucentis effective for proliferative diabetic retinopathy
A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferativeRead More
A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferativeRead More
Early signs of diabetic retinopathy can be detected through a comprehensive dilated eye exam.
Read More